Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna L Lindahl

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Breathe (Sheffield, England)|July 17, 2025
Indwelling pleural catheters and medical thoracoscopyValentina Luzzi, Anna L Lindahl, Sara Tomassetti
Breathe (Sheffield, England)|April 21, 2025
"Regression to the truth": lessons learned from negative IPF trialsAthina Trachalaki, Anna L Lindahl, Simone Petrarulo, et al.
Infectious Diseases (London, England)|August 10, 2023
Persisting symptoms common but inability to work rare: a one-year follow-up study of Finnish hospitalised COVID-19 patientsAnna L Lindahl, Miia Aro, Jere Reijula, et al.
Infectious Diseases (London, England)|June 19, 2023
Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case reportAnna L Lindahl, Maarit J Ahava, Mia Haukipää, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Breathe (Sheffield, England)|July 17, 2025
Indwelling pleural catheters and medical thoracoscopyValentina Luzzi, Anna L Lindahl, Sara Tomassetti
Breathe (Sheffield, England)|April 21, 2025
"Regression to the truth": lessons learned from negative IPF trialsAthina Trachalaki, Anna L Lindahl, Simone Petrarulo, et al.
Infectious Diseases (London, England)|August 10, 2023
Persisting symptoms common but inability to work rare: a one-year follow-up study of Finnish hospitalised COVID-19 patientsAnna L Lindahl, Miia Aro, Jere Reijula, et al.
Infectious Diseases (London, England)|June 19, 2023
Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case reportAnna L Lindahl, Maarit J Ahava, Mia Haukipää, et al.
Pageof 1